PRAME 抗体 (AA 1-509) (FITC)
-
- 抗原 See all PRAME 抗体
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
-
抗原表位
- AA 1-509
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This PRAME antibody is conjugated to FITC
- 应用范围
- 请咨询
- 交叉反应
- 人
- 纯化方法
- >95%, Protein G purified
- 免疫原
- Recombinant Human Melanoma antigen preferentially expressed in tumors protein (1-509AA)
- 亚型
- IgG
- Top Product
- Discover our top product PRAME Primary Antibody
-
-
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
- 别名
- PRAME (PRAME 产品)
- 别名
- PRAME antibody, CT130 antibody, MAPE antibody, OIP-4 antibody, OIP4 antibody, 4930534P07Rik antibody, preferentially expressed antigen in melanoma antibody, PRAME antibody, Prame antibody
- 背景
-
Background: Functions as a transcriptional repressor, inhibiting the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG. Prevents retinoic acid-induced cell proliferation arrest, differentiation and apoptosis.
Aliases: 4930534P07Rik antibody, Cancer/testis antigen 130 antibody, CT130 antibody, MAPE antibody, Melanoma antigen preferentially expressed in tumors antibody, OIP 4 antibody, OIP-4 antibody, OIP4 antibody, OPA interacting protein 4 antibody, Opa interacting protein OIP4 antibody, OPA-interacting protein 4 antibody, PRAME antibody, PRAME_HUMAN antibody, Preferentially expressed antigen in melanoma antibody, Preferentially expressed antigen of melanoma antibody, RP23-250F8.3 antibody
- UniProt
- P78395
- 途径
- Retinoic Acid Receptor Signaling Pathway, Nuclear Hormone Receptor Binding
-